$1.380
+0.143 (+10.39%)At close
Price Predictions
Open in app to unlock longer-horizon forecasts.
CMMB Prediction & Forecast by Similar Chart Analysis
Alphio's CMMB stock price prediction model matches the current Chemomab Therapeutics Ltd tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $1.38 (-0.24%). The 1-week path is $1.41 (+2.42%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
Should I Buy Chemomab Therapeutics Ltd Stock?
Chemomab Therapeutics Ltd. (CMMB) appears to be a good buy right now, trading at $1.38, which is significantly below its 52-week high of $2.99, indicating potential upside. The stock has shown a strong 5-day change of +18.96%, suggesting positive momentum. However, the company has a negative net income with losses reaching -2,165,000 USD in Q2 2026, which presents a risk to consider.
CMMB stock price ended at $1.38 on Friday, after rising +10.39%
Chemomab Therapeutics Ltd (CMMB) last closed at $1.3799, gaining +10.39%. These facts feed the 1-day and 1-week CMMB price prediction above.
Forecast Drivers
Chemomab Therapeutics Ltd (CMMB) forecast drivers combine similar chart patterns, seasonality, and moving averages.
Similar patterns
Bullish
Seasonality
Bearish
SMA 20
Bullish
SMA 200
Bearish
Similar Chart Patterns
Stocks whose recent price path most closely matches CMMB, ranked by similarity.
Seasonality analysis for CMMB
Historically the probability of a positive November return for CMMB is 45.45%. August offers the highest probability of a positive month at 62.50%, while January is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
10-year price projections for CMMB
| Month | Min Price | Avg Price | Max Price | Potential ROI |
|---|---|---|---|---|
| Nov 2026 | $1.06 | $1.07 | $1.13 | -22.58% |
| Dec 2026 | $1.01 | $1.21 | $1.23 | -12.48% |
In 2026, Chemomab Therapeutics Ltd (CMMB) is projected to range from $1.01 to $1.23.
Chemomab Therapeutics Ltd 2026 monthly forecast
In Nov 2026, Chemomab Therapeutics Ltd is projected to average $1.07, with a low of $1.06 and high of $1.13.
In Dec 2026, Chemomab Therapeutics Ltd is projected to average $1.21, with a low of $1.01 and high of $1.23.
Related articles
- How to Rebalance a Concentrated Stock Portfolio in 2026: Mag7 Drift, Tax-Aware Trims, and Practical Rebalance a concentrated stock portfolio in 2026: Mag7 drift risk, 5pp bands, tax-aware trims, RSP/IWM diversifiers, and single-name caps.
- Small Cap Stocks Investing Guide 2026: Russell 2000, Fed Hikes, and the Financing TradeSmall-cap stocks investing guide 2026: Russell 2000 vs S&P, IWM rate sensitivity, floating-rate debt, Fed hikes, valuation discounts, and a practical checklist.
- Santa Claus Rally and the Year-End Stock Market: Investor Guide for Late 2026Santa Claus rally explained: 7-day window stats since 1950, Nov–Dec seasonality, post-midterm 2026 setup, and a risk-managed year-end investing playbook.
This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.